Status:
COMPLETED
Effectiveness of Varenicline: Testing Individual Differences
Lead Sponsor:
The Mind Research Network
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Smoking Addiction
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
The study will evaluate the effectiveness of smoking cessation using Varenicline versus placebo. Effectiveness will be measured by the average number of cigarettes smoked per smoking day for up to 36 ...
Eligibility Criteria
Inclusion
- 18 yrs to 55 yrs
- smoker
Exclusion
- Medical Contraindications
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT01228175
Start Date
March 1 2010
End Date
March 1 2016
Last Update
May 9 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Mind Research Network
Albuquerque, New Mexico, United States, 87106